赵曙
哈尔滨医科大学附属肿瘤医院 血液科
一项II期、单臂、开放单中心的临床研究
2022-11-05
原发中枢神经系统淋巴瘤 (PCNSL) 诊疗现状及探索
2022-08-12
CACA淋巴瘤巡讲暨EHA淋巴瘤云端传递会
2022-07-17
lbrutinib plus Obinutuzumab as Frontline Therapy for ChronicLymphocytic Leukemia ls Associated with a Lower Rate ofInfusion-Related Reactions and with Sustained Remissions afterIbrutinib Discontinuation: A Single-Arm, Open-Label,Phase1b/2 Clinical Trial N
2022-05-06
群英荟 | 淋巴瘤诊疗研究解读系列会——第五期
2022-05-06
1
一项II期、单臂、开放单中心的临床研究
2
原发中枢神经系统淋巴瘤 (PCNSL) 诊疗现状及探索
3
CACA淋巴瘤巡讲暨EHA淋巴瘤云端传递会
4
lbrutinib plus Obinutuzumab as Frontline Therapy for ChronicLymphocytic Leukemia ls Associated with a Lower Rate ofInfusion-Related Reactions and with Sustained Remissions afterIbrutinib Discontinuation: A Single-Arm, Open-Label,Phase1b/2 Clinical Trial N
5
群英荟 | 淋巴瘤诊疗研究解读系列会——第五期